default author photo

Xinyue Zhang

Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China

SCHOLARLY PAPERS

1

DOWNLOADS

26

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Phase II Trial of Stereotactic Body Radiotherapy With Sunitinib Versus Sunitinib Alone in Newly Diagnosed Oligometastatic Renal Cell Carcinoma

Number of pages: 28 Posted: 30 Sep 2025
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Sun Yat-sen University (SYSU) - Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Independent
Downloads 26 (1,372,601)

Abstract:

Loading...

Metastasis-directed therapy, Oligometastatic, Renal cell carcinoma, Stereotactic body radiotherapy, Sunitinib